Recent Developments in Chinese Antibribery Laws and Enforcement

Published date06 August 2013
Law FirmAkin Gump Strauss Hauer & Feld LLP
Subject MatterAnti-Bribery,Bribery,China,Compliance,Enforcement,GlaxoSmithKline,Nutritional Supplements,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT